US 11680093
Monoclonal antibodies that specifically bind to matrilin 3 and their use
granted A61KA61K2039/505A61K47/6811
Quick answer
US patent 11680093 (Monoclonal antibodies that specifically bind to matrilin 3 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 40
- CPC classes
- A61K, A61K2039/505, A61K47/6811, A61K47/6843